The latest edition of the Provider's Digest, HCPLive's monthly newsletter spotlighting regulatory decisions and pipeline news, is now live! In our July 2024 recap, we spotlight 9 FDA decisions, 6 submissions or new designations, and 5 topline data announcements. Be sure to subscribe for a recap of the therapies, companies, and individuals moving the needle in healthcare during the past month, delivered on the first Saturday of each new month! #FDANews #Healthcare #Medicine
HCPLive
Media Production
Cranbury, NJ 3,318 followers
Comprehensive clinical news that provide clinicians with up-to-date specialty and disease-specific information.
About us
HCPLive provides health care professionals with up-to-date specialty and disease-specific news, clinical information, and other resources to help provide better care to patients. On HCPLive.com, you will find in-depth conference coverage and information about upcoming meetings, perspective on regulatory news, and multimedia content featuring key opinion leaders. Get all the latest news on individual medical conditions in our "condition centers": • Cardiology • Endocrinology • Gastroenterology • Ophthalmology • Neurology • Pain Management • Pediatrics • Primary Care • Psychiatry • Rheumatology • Urology
- Website
-
http://www.HCPLive.com
External link for HCPLive
- Industry
- Media Production
- Company size
- 2-10 employees
- Headquarters
- Cranbury, NJ
- Type
- Privately Held
- Founded
- 1957
- Specialties
- Managed Care, primary care, family medicine, Healthcare news, Internal Medicine, Medicine, Medical News, FDA News, and Cardiology
Locations
-
Primary
2 Clarke Drive
Suite 100
Cranbury, NJ 08512, US
Employees at HCPLive
Updates
-
With such a rapid rate of advancement for pharmacologic therapies in cardiometabolic syndromes, conversations on the safety and efficacy of combination therapy have risen to the forefront of discussions. At #ESCCongress, we sat down with Brendon L Neuen, MBBS, PhD, of The George Institute for Global Health and Royal North Shore Hospital, to discuss a study he led examining the topic of combination GLP-1 RA and SGLT2 inhibitor use on cardiovascular and kidney outcomes in people with #Type2Diabetes using data from FLOW, Harmony Outcomes, and AMPLITUDE-O. https://lnkd.in/eX2_SXa3 #Cardiology #Nephrology
-
Need a breakdown of all the finerenone (Kerendia; Bayer) data from #ESCCongress? Check out the latest episode of #DontMissABeat, where FINE-HEART principal investigator Muthu Vaduganathan, MD, MPH, of Brigham and Women's Hospital, plays the role of co-host and special guest as he sits down with Stephen Greene, MD, of Duke Heart, for a deep dive into FINEARTS-HF, FINE-HEART, and MRAs in heart failure with preserved ejection fraction. https://lnkd.in/e6eTDdFb
-
Our time on-site at #ESCCongress is over but you can catch up on all the top headlines and get perspective from leading experts and trialist by heading over to our conference coverage page: https://lnkd.in/eQ8CwJQF #Cardiology
-
-
Another on-site day at #ESCCongress in the books. Catch up on the day’s top headlines over on our conference coverage page: https://www.hcplive.com #Cardiology
-
-
Sunday Spotlight 🌟: Our 3rd edition of Qazi Corner, a quarterly digestive disease newsletter, in 2024 highlighted poignant and relevant topics in gastroenterology from Taha Qazi and the team at Cleveland Clinic. In an accompanying interview, Qazi described considerations for GLP-1 RA use in the context of endoscopic procedures, given their impact on gastric emptying and bowel motility. Check out the newsletter here: https://lnkd.in/em8Gm8xr #Gastroenterology #QaziCorner
-
An analysis of the SCORED trial from #ESCCongress highlights the effect of the SGLT1/2 inhibitor sotagliflozin (Inpefa; Lexicon Pharmaceuticals, Inc.) on heart failure outcomes based on diabetes duration. Check out our interview with Rahul Aggarwal, MD, of Brigham and Women's Hospital, to learn more: https://lnkd.in/e5nQdZNT #Diabetes #HeartFailure Deepak L. Bhatt, MD, MPH, MBA
-
Women with endometriosis experience an approximately 20% greater risk of significant cardiac outcomes, including heart attack and stroke, compared with women without endometriosis. These data were presented at the European Society of Cardiology Congress 2024 by Eva Havers-Borgersen, MD, Rigshospitalet Copenhagen University Hospital. Read more here: https://lnkd.in/eyH9EwQP #WomensHealth #Cardiology
-
-
We’re here to help you keep up with changing recommendations in type 2 #diabetes management. You can earn free #CE/CME in this interactive activity. You'll meet 3 patients and make clinical decisions as each case progresses. Meet the patients: https://bit.ly/3T0W57k
-
-
Back on-site for day 2 of #ESCCongress. Catch up on what you missed from day 1 and follow along for more updates throughout the day on our conference coverage page: https://lnkd.in/eQ8CwJQF #Cardiology
-